← Back to Search

Behavioral symptom management for Sickle Cell Disease

N/A
Waitlist Available
Led By Claudia Campbell, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 36 weeks
Awards & highlights

Study Summary

This trial is testing whether better sleep can ease pain and improve brain function in people with sickle cell disease.

Eligible Conditions
  • Sickle Cell Disease
  • Sleep Disorder
  • Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in Central Sensitization Index
Change in Clinical pain as assessed by the Brief Pain Inventory
Change in functional connectivity/cognitive task

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sickle cell disease managementExperimental Treatment1 Intervention
Five sessions working one-on-one with a study interventionist, either in person or by telephone. Includes monitoring of the individual's sleep pattern, information about sickle cell disease and its management, and information about improving sleep and managing pain.
Group II: Behavioral symptom managementExperimental Treatment1 Intervention
Five sessions working one-on-one with a study interventionist, either in person or by telephone. Includes monitoring of the individual's sleep pattern, feedback and goals for improving sleep and pain management, and addressing cognitive and emotional strategies for managing sleep and pain.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral symptom management
2017
N/A
~60

Find a Location

Who is running the clinical trial?

University of MarylandOTHER
161 Previous Clinical Trials
302,232 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,274 Previous Clinical Trials
14,840,460 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,847 Previous Clinical Trials
47,818,179 Total Patients Enrolled

Media Library

Behavioral sleep interventions Clinical Trial Eligibility Overview. Trial Name: NCT03150433 — N/A
Sickle Cell Disease Research Study Groups: Behavioral symptom management, Sickle cell disease management
Sickle Cell Disease Clinical Trial 2023: Behavioral sleep interventions Highlights & Side Effects. Trial Name: NCT03150433 — N/A
Behavioral sleep interventions 2023 Treatment Timeline for Medical Study. Trial Name: NCT03150433 — N/A
~8 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top